Literature DB >> 19406039

NCCN clinical practice guidelines in oncology: hepatobiliary cancers.

Al B Benson1, Thomas A Abrams, Edgar Ben-Josef, P Mark Bloomston, Jean F Botha, Bryan M Clary, Anne Covey, Steven A Curley, Michael I D'Angelica, Rene Davila, William D Ensminger, John F Gibbs, Daniel Laheru, Mokenge P Malafa, Jorge Marrero, Steven G Meranze, Sean J Mulvihill, James O Park, James A Posey, Jasgit Sachdev, Riad Salem, Elin R Sigurdson, Constantinos Sofocleous, Jean-Nicolas Vauthey, Alan P Venook, Laura Williams Goff, Yun Yen, Andrew X Zhu.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19406039      PMCID： PMC4461147          DOI： 10.6004/jnccn.2009.0027

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN： 1540-1405            Impact factor:   11.908


× No keyword cloud information.
  201 in total

1.  Improving the prediction of hepatocellular carcinoma in cirrhotic patients with an arterially-enhancing liver mass.

Authors:  Jorge A Marrero; Hero K Hussain; Hahn V Nghiem; Ramsey Umar; Robert J Fontana; Anna S Lok
Journal:  Liver Transpl       Date:  2005-03       Impact factor: 5.799

2.  A western surgical experience of peripheral cholangiocarcinoma.

Authors:  S V Berdah; J R Delpero; S Garcia; J Hardwigsen; Y P Le Treut
Journal:  Br J Surg       Date:  1996-11       Impact factor: 6.939

3.  A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization.

Authors:  L Lladó; J Virgili; J Figueras; C Valls; J Dominguez; A Rafecas; J Torras; J Fabregat; J Guardiola; E Jaurrieta
Journal:  Cancer       Date:  2000-01-01       Impact factor: 6.860

4.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.

Authors:  Giulio Marchesini; Elisabetta Bugianesi; Gabriele Forlani; Fernanda Cerrelli; Marco Lenzi; Rita Manini; Stefania Natale; Ester Vanni; Nicola Villanova; Nazario Melchionda; Mario Rizzetto
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

5.  The model for end-stage liver disease-based Japan Integrated Scoring system may have a better predictive ability for patients with hepatocellular carcinoma undergoing locoregional therapy.

Authors:  Teh-Ia Huo; Han-Chieh Lin; Yi-Hsiang Huang; Jaw-Ching Wu; Jen-Huei Chiang; Pui-Ching Lee; Shou-Dong Lee
Journal:  Cancer       Date:  2006-07-01       Impact factor: 6.860

6.  Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA.

Authors:  John P Duffy; Andrew Vardanian; Elizabeth Benjamin; Melissa Watson; Douglas G Farmer; Rafik M Ghobrial; Gerald Lipshutz; Hasan Yersiz; David S K Lu; Charles Lassman; Myron J Tong; Jonathan R Hiatt; Ronald W Busuttil
Journal:  Ann Surg       Date:  2007-09       Impact factor: 12.969

7.  Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm.

Authors:  Shi-Ming Lin; Chun-Jung Lin; Chen-Chun Lin; Chao-Wei Hsu; Yi-Cheng Chen
Journal:  Gastroenterology       Date:  2004-12       Impact factor: 22.682

Review 8.  Intrahepatic cholangiocarcinoma: macroscopic type and stage classification.

Authors:  Susumu Yamasaki
Journal:  J Hepatobiliary Pancreat Surg       Date:  2003

9.  Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis.

Authors:  Laura M Kulik; Brian I Carr; Mary F Mulcahy; Robert J Lewandowski; Bassel Atassi; Robert K Ryu; Kent T Sato; Al Benson; Albert A Nemcek; Vanessa L Gates; Michael Abecassis; Reed A Omary; Riad Salem
Journal:  Hepatology       Date:  2008-01       Impact factor: 17.425

10.  Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.

Authors:  Alejandro Forner; Ramón Vilana; Carmen Ayuso; Lluís Bianchi; Manel Solé; Juan Ramón Ayuso; Loreto Boix; Margarita Sala; María Varela; Josep M Llovet; Concepció Brú; Jordi Bruix
Journal:  Hepatology       Date:  2008-01       Impact factor: 17.425
View more
  219 in total

Review 1.  Gallbladder cancer.

Authors:  Mislav Rakić; Leonardo Patrlj; Mario Kopljar; Robert Kliček; Marijan Kolovrat; Bozo Loncar; Zeljko Busic
Journal:  Hepatobiliary Surg Nutr       Date:  2014-10       Impact factor: 7.293

2.  Unresectable Hepatocellular Carcinoma Due to Portal Venous Thrombosis: Focal Stereotactic Body Radiation Therapy Can Promote Resectability.

Authors:  Andrew Y Lee; Tianming Wu; Michael W Vannier; Giuliano Testa; Stanley L Liauw
Journal:  J Gastrointest Cancer       Date:  2012-09

3.  Role of operative therapy in non-cirrhotic patients with metastatic hepatocellular carcinoma.

Authors:  Victor Zaydfudim; Rory L Smoot; Clancy J Clark; Michael L Kendrick; Florencia G Que; Michael B Farnell; David M Nagorney
Journal:  J Gastrointest Surg       Date:  2012-05-30       Impact factor: 3.452

4.  Predictive value of microRNAs as novel biomarkers in detection of lymphoma.

Authors:  Yongjing Wang; Dianshui Sun; Juandong Wang; Aixia Dou; Chengyun Zheng
Journal:  Int J Clin Exp Med       Date:  2015-08-15

Review 5.  Liver Transplantation for Cholangiocarcinoma: Insights into the Prognosis and the Evolving Indications.

Authors:  Guergana G Panayotova; Flavio Paterno; James V Guarrera; Keri E Lunsford
Journal:  Curr Oncol Rep       Date:  2020-04-16       Impact factor: 5.075

6.  Advances and Future Directions in the Treatment of Hepatocellular Carcinoma.

Authors:  Ashil J Gosalia; Paul Martin; Patricia D Jones
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-07

Review 7.  Treatment of intermediate-stage hepatocellular carcinoma.

Authors:  Alejandro Forner; Marine Gilabert; Jordi Bruix; Jean-Luc Raoul
Journal:  Nat Rev Clin Oncol       Date:  2014-08-05       Impact factor: 66.675

Review 8.  Clinical trials of combined molecular targeted therapy and locoregional therapy in hepatocellular carcinoma: past, present, and future.

Authors:  Hwi Young Kim; Joong-Won Park
Journal:  Liver Cancer       Date:  2014-03       Impact factor: 11.740

9.  Predicting Treatment Response to Intra-arterial Therapies for Hepatocellular Carcinoma with the Use of Supervised Machine Learning-An Artificial Intelligence Concept.

Authors:  Aaron Abajian; Nikitha Murali; Lynn Jeanette Savic; Fabian Max Laage-Gaupp; Nariman Nezami; James S Duncan; Todd Schlachter; MingDe Lin; Jean-François Geschwind; Julius Chapiro
Journal:  J Vasc Interv Radiol       Date:  2018-03-14       Impact factor: 3.464

10.  Adjuvant therapy for intrahepatic cholangiocarcinoma: the debate continues.

Authors:  Andrew X Zhu; Jennifer J Knox
Journal:  Oncologist       Date:  2012-12-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.